Medicure Phamaceuticals Private Limited
Pharmaceutical company trading, manufacturing, and selling pharmaceutical products and related items.
2005 | Delhi (India) | Active
Medicure Phamaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 6.55 M
- Revenue Growth -15.35%
- Profit Growth -5.13%
- Ebitda -30.40%
- Net Worth 20.84%
- Total Assets -6.25%
About Medicure Phamaceuticals
Medicure Phamaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 November 2005 and has a history of 19 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.55 M.
Rakesh Sethi and Seema Sethi serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231DL2005PTC143063
- Company No.
143063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2005
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Medicure Phamaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Sethi  | Director | 28-Nov-2005 | Current |
| Seema Sethi | Director | 28-Nov-2005 | Current |
Financial Performance of Medicure Phamaceuticals.
Medicure Phamaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 15.35% decrease. The company also saw a slight decrease in profitability, with a 5.13% decrease in profit. The company's net worth Soared by an impressive increase of 20.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicure Phamaceuticals?
In 2020, Medicure Phamaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹6.55 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.50 Cr
- Others : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2021 | Indian Overseas Bank | ₹5.00 M | Open |
| 14 Feb 2018 | Others | ₹1.00 M | Open |
| 13 Feb 2018 | Others | ₹0.55 M | Open |
How Many Employees Work at Medicure Phamaceuticals?
Unlock and access historical data on people associated with Medicure Phamaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicure Phamaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicure Phamaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.